Biodexa PharmaceuticalsBDRX
13F holders, Q3 2025 (September 30)4holders
$6.65avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Biodexa Pharmaceuticals PLC (BDRX) in their 13F filings. The largest holders were UBS Group AG ($46K), GAMMA Investing LLC ($9K) and SBI Securities Co., Ltd. ($765).
- Company
- Biodexa Pharmaceuticals PLC
- CUSIP
- 59564R880
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $56K |
| Exits | 0 | $0 |
Ownership 4 holders
| UBS Group AG | 0.00% | New | 6,925 | $46K |
| GAMMA Investing LLC | 0.00% | New | 1,352 | $9K |
| SBI Securities Co., Ltd. | 0.00% | New | 115 | $765 |
| Rhumbline Advisers | 0.00% | New | 5 | $32 |
"% of holder's portfolio" is BDRX's weight in each manager's 13F, not the share of Biodexa Pharmaceuticals PLC the manager owns.